Nous sommes heureux de présenter aux parties intéressées ce cinquième rapport portant sur la surveillance des maladies infectieuses que vous pouvez utiliser dans vos processus de décisions.
https://www.rand.org/pubs/research_reports/RR1575.htmlCe premier chapitre du Guide de la pratique transfusionnelle4 donne une vue d’ensemble du système d’approvisionnement en sang du Canada, des règlements et des normes en place ainsi que des organisations et des professionnels qui, combinés, veillent à ce que la médecine transfusionnelle pratiquée au Canada soit sûre.
The development and execution of clinical trials that evaluate hemostatic products are impeded by the lack of commonly accepted outcomes by the necessary funding and regulatory agencies. The establishment of clinically relevant outcomes that are widely accepted for patients in clinical trials evaluating hemostatic blood products and therapeutics will enhance the ability to perform high quality clinical trials.
Canadian Blood Services recently updated the equipment it uses to produce components (red blood cells, plasma and platelets) from whole blood donations. In May 2019, the mammoth task of implementing the new equipment at manufacturing sites across the country was completed. But how did the organization choose which equipment to implement in the first place? Let’s look back at some early research work that helped the organization gather the evidence it needed to support this change.
The Centre for Innovation’s annual progress report details the achievements made over the past year by Canadian Blood Services’ network of scientists, medical experts, research partners, and collaborators.
The Canadian Society for Transfusion Medicine’s annual conference took place in Calgary, Alberta in early June. The Centre for Innovation’s Geraldine Walsh was there and shares her highlights.
